Recently, the Sichuan Institute of Industry and Information Technology released the "2024 List of Top 100 New Economy Enterprises in Sichuan Province". Grand Shuyang Life Sciences (Chengdu) Co., Ltd. (hereinafter referred to as "Grand Shuyang") was successfully selected as one of the TOP 100 new economy enterprises with its outstanding innovation capabilities, robust market performance, and continuously growing industrial influence.

Multi-dimensional quantitative evaluation to comprehensively assess the overall strength of enterprises

The selection of this list was based on relevant global research and evaluation index systems, with the evaluation criteria refined and optimized to align with the industrial landscape of Sichuan. The selection process involved gathering economic data and development insights of enterprises through various channels, including enterprise application materials, government public data, market financing records, and public annual reports for scientific and quantitative analysis. The selection criteria primarily focus on six key aspects: enterprise scale, innovation level, growth rate, profitability, social contribution, and social impact. The evaluation encompasses 15 detailed indicators, including revenue from new economy sectors, financing valuation, R&D expenditure, profit margin, and tax payments.

Continually strengthening core competitiveness and steadily increasing market share

As a growth-oriented enterprise backed by Sichuan Provincial People's Government, Grand Shuyang has consistently strengthened its industry foundation, steadily expanded its market presence, and driven revenue growth in new economy sectors. Through lean production management, exceptional R&D technologies, and a well-integrated industrial chain, Grand Shuyang has established itself as one of the leading enterprises in the industry. The company's products not only fulfill Chinese market needs but also actively pursue an international strategy to expand into global markets.

Looking ahead, Grand Shuyang will continue to strive for progress

Grand Shuyang will adhere to a development path of "high quality standards, comprehensive product coverage, and market internationalization". It aims to consolidate the driving forces for industry advancement and harness synergy for rapid growth, striving to become an "international high-quality service provider across the entire plasma-derived product chain" to safeguard human health, enhance the quality of life, and co-create a better future.